Resultados globales: 2 registros encontrados en 0.02 segundos.
Artículos, Encontrados 2 registros
Artículos Encontrados 2 registros  
1.
11 p, 547.4 KB Pretransplant Consolidation Is Not Beneficial for Adults with ALL Undergoing Myeloablative Allogeneic Transplantation / Bejanyan, Nelli (University of Minnesota) ; Zhang, Mei-Jie (Medical College of Wisconsin) ; Wang, Hai-Lin (Medical College of Wisconsin) ; Lazaryan, Aleksandr (University of Minnesota) ; de Lima, Marcos (University Hospitals Case Medical Center) ; Marks, David I. (University Hospitals Bristol NHS Trust) ; Sandmaier, Brenda M. (Fred Hutchinson Cancer Research Center) ; Bachanova, Veronika (University of Minnesota) ; Rowe, Jacob (Shaare Zedek Medical Center) ; Tallman, Martin (Memorial Sloan Kettering Cancer Center) ; Kebriaei, Partow (The University of Texas MD Anderson Cancer Center) ; Kharfan-Dabaja, Mohamed (H. Lee Moffitt Cancer Center and Research Institute) ; Peter Gale, Robert (Imperial College London) ; Lazarus, Hillard M. (University Hospitals Cleveland Medical Center) ; Ustun, Celalettin (University of Minnesota) ; Copelan, Edward (Carolinas HealthCare System) ; Ky Hamilton, Betty (Cleveland Clinic Taussig Cancer Institute) ; Schiller, Gary (David Geffen School of Medicine at UCLA) ; Hogan, Willian (Mayo Clinic Rochester) ; Hashmi, Shahrukh (King Faisal Specialist Hospital and Research Centre (Aràbia Saudita)) ; Seftel, Matthew (CancerCare Manitoba) ; Kanakry, Christopher G. (National Institutes of Health (Bethesda, Estats Units d'Amèrica)) ; Olsson, Richard F. (Uppsala University) ; Martino Bofarull, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ; Saber, Wael (Medical College of Wisconsin) ; Khoury, H.Jean (Emory University Hospital) ; Weisdorf, Daniel J. (University of Minnesota) ; Universitat Autònoma de Barcelona
Allogeneic hematopoietic cell transplantation (alloHCT) is curative for patients with acute lymphoblastic leukemia (ALL) who achieve complete remission (CR1) with chemotherapy. However, the benefit of consolidation chemotherapy remains uncertain in patients undergoing alloHCT. [...]
2018 - 10.1016/j.bbmt.2017.12.784
Biology of blood and marrow transplantation, Vol. 24 Núm. 5 (may 2018) , p. 945-955  
2.
10 p, 1.3 MB Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission : analysis from CALGB 10403 and the CIBMTR / Wieduwilt, Matthew J. (University of California) ; Stock, Wendy (University of Chicago Medicine) ; Advani, Anjali (Cleveland Clinic) ; Luger, Selina (University of Pennsylvania Medical Center) ; Larson, Richard A. (University of Chicago Medicine) ; Tallman, Martin (Memorial Sloan Kettering Cancer Center. Leukemia Service, Department of Medicine) ; Appelbaum, Frederick (Fred Hutchinson Cancer Research Center) ; Zhang, Mei-Jie (Medical College of Wisconsin. Division of Biostatistics) ; Bo-Subait, Khalid (Medical College of Wisconsin) ; Wang, Hai-Lin (Medical College of Wisconsin) ; Bhatt, Vijaya Raj (University of Nebraska Medical Center) ; Dholaria, Bhagirathbhai (Vanderbilt University Medical Center) ; Eapen, Mary (Medical College of Wisconsin) ; Hamadani, Mehdi (Medical College of Wisconsin) ; Jamy, Omer (University of Alabama at Birmingham) ; Prestidge, Tim (Starship Children's Hospital (Auckland, Nova Zelanda)) ; Pulsipher, Michael (Children's Hospital Los Angeles Cancer) ; Ritchie, David (Peter MacCallum Cancer Centre) ; Rizzieri, David (Duke University) ; Sharma, Akshay (St. Jude Children's Research Hospital (Memphis, Estats Units d'Amèrica)) ; Barba, Pere (Hospital Universitari Vall d'Hebron) ; Sandmaier, Brenda M. (Fred Hutchinson Cancer Research Center) ; de Lima, Marcos (University Hospitals Case Medical Center) ; Kebriaei, Partow (The University of Texas MD Anderson Cancer Center) ; Litzow, Mark (Mayo Clinic.) ; Saber, Wael (Medical College of Wisconsin) ; Weisdorf, Daniel (University of Minnesota) ; Universitat Autònoma de Barcelona
Optimal post-remission therapy for adolescents and young adults (AYAs) with Ph-negative acute lymphoblastic leukemia (ALL) in first complete remission (CR1) is not established. We compared overall survival (OS), disease-free survival (DFS), relapse, and non-relapse mortality (NRM) for patients receiving post-remission therapy on CALGB 10403 to a cohort undergoing myeloablative (MA) allogeneic hematopoietic cell transplantation (HCT) in CR1. [...]
2021 - 10.1038/s41375-021-01213-5
Leukemia, Vol. 35 (march 2021) , p. 2076-2085  

Vea también: autores con nombres similares
1 Sandmaier, B.
2 Sandmaier, B.M.
1 Sandmaier, Brenda
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.